Amplatzer Cardiac Plug

Amplatzer Cardiac Plug
Amplatzer Cardiac Plug
204731

Number of Participants

3000

Eligibility

Nonvalvular atrial fibrillation; patient must be eligible for warfarin or dabigatran therapy and be at moderate to high risk of stroke (CHADS2 =2)

Purpose

The purpose of this study is to compare the effectiveness of an investigational device to the usual medical treatment for atrial fibrillation.

Treatment

Participants will be randomly assigned to receive either standard medical therapy or the investigational device implanted in the heart.

Principal Investigator

Fred Leya

M.D.
Cardiology
Professor

Enrollment

(708) 216-9449 or (7

More Clinical Trials

See Also

© 2011 Loyola University Chicago Health Sciences Division. All rights reserved.  &npsp; Privacy Policy   Privacy Policy